Literature DB >> 17642798

Health-related quality of life in emotionally related kidney transplantation: deductions from a comparative study.

F A Arogundade1, M A Abd-Essamie, R S Barsoum.   

Abstract

The health related quality of life (HRQOL) has not been compared between live related and un-related donations. We set out to assess the HRQOL in 52 recipients and compare them to 68 HD patients using the Karnofsky performance status scale. Statistical package for social sciences (SPSS) was used for data analysis. The duration of end-stage renal disease was 7.14 + 3.8 years and 5.30 + 4.15 years for transplant and HD patients respectively. The HRQOL was similar in both living and emotionally related recipients but both were significantly better than that of HD patients (P < 0.0001). There was significant negative correlation between HRQOL and age (r = -0.363, P < 0.0001), serum creatinine (r = -0.502, P = 0.0001), serum urea (r = -0.493, P < 0.0001), serum phosphate (r = -0.363, P = 0.003) and calcium-phosphate product (r = -0.305, P < 0.0001). There was significant positive correlation between HRQOL and haemoglobin (r = +0.495, P < 0.0001) and serum calcium (r = +0.247, P = 0.017). Age of the patients appears to be the most important determinant of HRQOL in the studied population. HRQOL was similar in the related and unrelated donors and was better than in hemodialysis patients.

Entities:  

Year:  2005        PMID: 17642798

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  2 in total

1.  Kidney transplantation in a low-resource setting: Nigeria experience.

Authors:  Fatiu Abiola Arogundade
Journal:  Kidney Int Suppl (2011)       Date:  2013-05

2.  Exploring quality of life among renal and liver transplant recipients.

Authors:  Abdulmalik Alkatheri; Abdulkareem Al Bekairy; Salah Aburuz; Amjad Qandil; Nabil Khalidi; Khalid Abdullah; Sayyari Al Sayyari; Rami Bustami; Shmeylan Al Harbi; Sultan Al Raddadi; Khalifah Al Thiab; Khalid Bin Saleh; Abdulrahman Al Shaya
Journal:  Ann Saudi Med       Date:  2015 Sep-Oct       Impact factor: 1.526

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.